Copyright
©2013 Baishideng Publishing Group Co.
World J Immunol. Jul 27, 2013; 3(2): 18-30
Published online Jul 27, 2013. doi: 10.5411/wji.v3.i2.18
Published online Jul 27, 2013. doi: 10.5411/wji.v3.i2.18
Table 2 Common clinical associations of paraproteins[70]
Disorder | Diagnostic features |
Monoclonal gammopathy of undetermined significance | All three criteria must be met: |
Serum monoclonal protein < 30 g/L | |
Clonal bone marrow plasma cells < 10% | |
Absence of end-organ damage ("CRAB"), e.g., hypercalcemia, renal insufficiency, anaemia and bone lesions due to the plasma cell disorder | |
Smouldering myeloma | Both criteria must be met: |
Serum monoclonal protein (IgG or IgA) > 30 g/L and/or clonal bone marrow plasma cells > 10% | |
Absence of "CRAB", as defined above | |
Multiple myeloma | All three criteria must be met: |
Clonal bone marrow plasma cells > 10% | |
Presence of serum and/or urinary monoclonal protein (except in patients with true non-secretory multiple myeloma) | |
Evidence of "CRAB", as defined above | |
Waldenström’s macroglobulinaemia | Both criteria must be met: |
IgM monoclonal gammopathy and | |
10% bone marrow infiltration (usually intertrabecular) by lymphoplasmacytic cells (morphology/immunophenotype)1 | |
IgM monoclonal gammopathy of undetermined significance | All three criteria must be met: |
Serum IgM monoclonal protein < 30 g/L | |
Bone marrow lymphoplasmacytic infiltration < 10% | |
No evidence of anemia, constitutional symptoms, hyperviscosity, lymphadenopathy or hepatosplenomegaly | |
Smoldering Waldenström’s macroglobulinemia | Both criteria must be met: |
Serum IgM monoclonal protein > 30 g/L and/or bone marrow lymphoplasmacytic infiltration > 10% | |
No evidence of end-organ damage such as anemia, constitutional symptoms, hyperviscosity, lymphadenopathy or hepatosplenomegaly due to a lymphoplasma cell proliferative disorder |
- Citation: Maher J. Role of the clinical immunology laboratory in disease monitoring. World J Immunol 2013; 3(2): 18-30
- URL: https://www.wjgnet.com/2219-2824/full/v3/i2/18.htm
- DOI: https://dx.doi.org/10.5411/wji.v3.i2.18